- £1.02bn
- £1.89bn
- $5.90bn
- 54
- 90
- 28
- 60
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,890 | 7,564 | 5,238 | 5,442 | 5,901 |
Cost of Revenue | |||||
Gross Profit | 1,122 | 728 | 620 | 665 | 710 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9,587 | 7,597 | 5,300 | 6,011 | 5,874 |
Operating Profit | 303 | -32.9 | -62.1 | -568 | 26.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 149 | -149 | -172 | -695 | -62.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 72.8 | -228 | -214 | -705 | -128 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 72 | -230 | -140 | -356 | -111 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 72 | -230 | -140 | -356 | -111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.222 | -0.003 | -0.112 | -0.014 | -0.085 |
Dividends per Share |